{
  "retracted": false,
  "timestamp": 1501545600000,
  "updates": [
    {
      "timestamp": 1585419716562,
      "identifier": {
        "doi": "10.2337/dc17-er08d"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.2337/dc16-1738"
  },
  "publisher": "American Diabetes Association",
  "title": "Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325â€“331"
}
